| 1 |
Galindo Torres BP, García Girón C, Alcaraz Ortega R, Saiz López P, Adiego Leza MI, Grijalba Uche MV. Knowledge and expectations about miRNAs as biomarkers in head and neck squamous cell cancers. Am J Otolaryngol 2023;44:103771. [PMID: 36603378 DOI: 10.1016/j.amjoto.2022.103771] [Reference Citation Analysis]
|
| 2 |
Lee H, Chun SH, Moon SY, Yoon J, Won HS, Hong SA, Kim SR, Cho K, Kang K, Lee S, Ahn Y, Hong JH, Ko YH. MicroRNA-769-3p Acts as a Prognostic Factor in Oral Squamous Cell Cancer by Modulating Stromal Genes. Cancers 2022;14:4373. [DOI: 10.3390/cancers14184373] [Reference Citation Analysis]
|
| 3 |
Chantre-justino M, Alves G, Delmonico L. Clinical applications of liquid biopsy in HPV‐negative and HPV‐positive head and neck squamous cell carcinoma: advances and challenges. Exploration of Targeted Anti-tumor Therapy 2022. [DOI: 10.37349/etat.2022.00099] [Reference Citation Analysis]
|
| 4 |
Xing L, Feng Z, Nie H, Liu M, Liu Y, Zhang X, Zhou H. Research progress and clinical application prospects of miRNAs in oral cancer. Mol Biol Rep 2022. [PMID: 35725854 DOI: 10.1007/s11033-022-07604-w] [Reference Citation Analysis]
|
| 5 |
Ma Y, Gao J, Guo H. miR-23a-3p Regulates Runx2 to Inhibit the Proliferation and Metastasis of Oral Squamous Cell Carcinoma. J Oncol 2022;2022:8719542. [PMID: 35342401 DOI: 10.1155/2022/8719542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Scholtz B, Horváth J, Tar I, Kiss C, Márton IJ. Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma. Pathogens 2022;11:229. [DOI: 10.3390/pathogens11020229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Sun Y, Li J, Zheng S. MiR-769-5p, Which Targets HDGF, Inhibits Cell Proliferation and Invasion in Nonsmall Cell Lung Cancer. Cancer Biother Radiopharm 2021. [PMID: 34978893 DOI: 10.1089/cbr.2021.0363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Subha ST, Chin JW, Cheah YK, Mohtarrudin N, Saidi HI. Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer. Mol Biol Rep 2021. [PMID: 34837627 DOI: 10.1007/s11033-021-06954-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Camuzi D, Simão TA, Dias F, Ribeiro Pinto LF, Soares-Lima SC. Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis. Cancers (Basel) 2021;13:5630. [PMID: 34830785 DOI: 10.3390/cancers13225630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Pérez-Ruiz E, Gutiérrez V, Muñoz M, Oliver J, Sánchez M, Gálvez-Carvajal L, Rueda-Domínguez A, Barragán I. Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma. Biomedicines 2021;9:1478. [PMID: 34680596 DOI: 10.3390/biomedicines9101478] [Reference Citation Analysis]
|
| 11 |
Liu X, Yang B, Zhang Y, Guo X, Yang Q, Liu X, Bai Q, Lu Q. miR-30a-5p inhibits osteogenesis and promotes periodontitis by targeting Runx2. BMC Oral Health 2021;21:513. [PMID: 34635105 DOI: 10.1186/s12903-021-01882-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Chang S, Chang M, Liu G, Xu D, Wang H, Sun R, Feng M. LncRNA OIP5-AS1 reduces renal epithelial cell apoptosis in cisplatin-induced AKI by regulating the miR-144-5p/PKM2 axis. Biomed J 2021:S2319-4170(21)00096-2. [PMID: 34311128 DOI: 10.1016/j.bj.2021.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 13 |
Saidak Z, Lailler C, Testelin S, Chauffert B, Clatot F, Galmiche A. Contribution of Genomics to the Surgical Management and Study of Oral Cancer. Ann Surg Oncol 2021. [PMID: 33846893 DOI: 10.1245/s10434-021-09904-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Rishabh K, Khadilkar S, Kumar A, Kalra I, Kumar AP, Kunnumakkara AB. MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review. Int J Mol Sci 2021;22:2561. [PMID: 33806361 DOI: 10.3390/ijms22052561] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 15 |
Menini M, De Giovanni E, Bagnasco F, Delucchi F, Pera F, Baldi D, Pesce P. Salivary Micro-RNA and Oral Squamous Cell Carcinoma: A Systematic Review. J Pers Med 2021;11:101. [PMID: 33557138 DOI: 10.3390/jpm11020101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Huang Y, Liu Z, Zhong L, Wen Y, Ye Q, Cao D, Li P, Liu Y. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. BMC Genomics 2020;21:691. [PMID: 33023466 DOI: 10.1186/s12864-020-07104-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 17 |
Kim S, Lee JW, Park YS. The Application of Next-Generation Sequencing to Define Factors Related to Oral Cancer and Discover Novel Biomarkers. Life (Basel) 2020;10:E228. [PMID: 33023080 DOI: 10.3390/life10100228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 18 |
Lin BZ, Wan SY, Lin MY, Chang CH, Chen TW, Yang MH, Lee YJ. Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor. Molecules 2020;25:E3609. [PMID: 32784458 DOI: 10.3390/molecules25163609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 19 |
Li H, Jiang J. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1. J Investig Med 2020;68:1282-8. [PMID: 32690597 DOI: 10.1136/jim-2020-001415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 20 |
Madhura MG, Rao RS, Patil S, Fageeh HN, Alhazmi A, Awan KH. Advanced diagnostic aids for oral cancer. Dis Mon 2020;66:101034. [PMID: 32594996 DOI: 10.1016/j.disamonth.2020.101034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 21 |
He L, Liao L, Du L. miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2. Int J Mol Med 2020;46:828-38. [PMID: 32626925 DOI: 10.3892/ijmm.2020.4638] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Wang H, Guo Y, Mi N, Zhou L. miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1. Mol Cell Probes 2020;52:101567. [PMID: 32259627 DOI: 10.1016/j.mcp.2020.101567] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 23 |
Morlandt A, Amm H. Genetics of Oral Cancer. Improving Outcomes in Oral Cancer 2020. [DOI: 10.1007/978-3-030-30094-4_7] [Reference Citation Analysis]
|
| 24 |
Zhuang Z, Yu P, Xie N, Wu Y, Liu H, Zhang M, Tao Y, Wang W, Yin H, Zou B, Hou J, Liu X, Li J, Huang H, Wang C. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma. Theranostics 2020;10:1433-53. [PMID: 31938073 DOI: 10.7150/thno.38507] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 25 |
Rapado-González Ó, López-López R, López-Cedrún JL, Triana-Martínez G, Muinelo-Romay L, Suárez-Cunqueiro MM. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy. Cells 2019;8:E1653. [PMID: 31861130 DOI: 10.3390/cells8121653] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 26 |
Chang M, Yan P, Zhang B, Zhang G, Wang J, Ge H, Han N, Du C, Shi W, Tian Y. MicroRNA-769-5p Promotes The Growth Of Glioma Cells By Targeting Lysine Methyltransferase 2A. Onco Targets Ther 2019;12:9177-87. [PMID: 31807002 DOI: 10.2147/OTT.S222836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 27 |
Liang LB, Zhu WJ, Chen XM, Luo FM. Plasma miR-30a-5p as an early novel noninvasive diagnostic and prognostic biomarker for lung cancer. Future Oncol 2019;15:3711-21. [PMID: 31664862 DOI: 10.2217/fon-2019-0393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 28 |
Xian Y, Wang L, Yao B, Yang W, Mo H, Zhang L, Tu K. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP. Biomed Pharmacother 2019;118:109343. [PMID: 31545279 DOI: 10.1016/j.biopha.2019.109343] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 29 |
Jin Y, Li Y, Wang X, Yang Y. Dysregulation of MiR-519d Affects Oral Squamous Cell Carcinoma Invasion and Metastasis by Targeting MMP3. J Cancer 2019;10:2720-34. [PMID: 31258780 DOI: 10.7150/jca.31825] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 30 |
Lu Z, He Q, Liang J, Li W, Su Q, Chen Z, Wan Q, Zhou X, Cao L, Sun J, Wu Y, Liu L, Wu X, Hou J, Lian K, Wang A. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer. Mol Ther Nucleic Acids 2019;16:471-80. [PMID: 31051332 DOI: 10.1016/j.omtn.2019.03.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 31 |
Sapna G, Gokul S. Next generation sequencing in oral disease diagnostics. World J Stomatol 2018; 6(2): 6-10 [DOI: 10.5321/wjs.v6.i2.6] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
